Periodontitis, Chronic

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Scaling and root planingN/A1 trial
Active Trials
NCT03264118Completed25Est. Dec 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Geistlich PharmaScaling and root planing

Clinical Trials (1)

Total enrollment: 25 patients across 1 trials

NCT03264118Geistlich PharmaScaling and root planing

Effects of Antimicrobial Photodynamic Therapy on Regeneration of Class II Furcation Lesions

Start: Apr 2017Est. completion: Dec 201825 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space